Treace Medical Concepts, Inc.
TMCI
Rank in Stocks
#14651
Treace Medical Concepts, Inc., a medical technology company, designs,... Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Share Price
$4.78
Last synced: 2026-11-09
Market Cap
$310.87M
Change (1 day)
18.61%
Change (1 year)
42.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Treace Medical Concepts, Inc. (TMCI)
Category
Healthcare
Operating Margin for Treace Medical Concepts, Inc. (TMCI)
Operating Margin as of November 2026 TTM: -26.17%
According to Treace Medical Concepts, Inc.'s latest financial reports, its current operating margin (TTM) is -26.17%. At the end of 2025 the company had an operating margin of -25.46%.
Operating Margin history for Treace Medical Concepts, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -26.17% | 2.79% |
| 2025 | -25.46% | -4.29% |
| 2024 | -26.60% | -3.20% |
| 2023 | -27.48% | 11.84% |
| 2022 | -24.57% | 40.48% |
| 2021 | -17.49% | -1,273.83% |
| 2020 | 1.49% | -116.61% |
| 2019 | -8.97% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.58% |
US
|
|
| 18.08% | -100.69% |
IE
|
|
| 21.25% | -100.81% |
US
|
|
| 21.05% | -100.80% |
US
|
|
| 28.09% | -101.07% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Treace Medical Concepts, Inc.'s operating margin
What is Treace Medical Concepts, Inc.'s operating margin?
Treace Medical Concepts, Inc.'s operating margin is -26.17%, as of Nov 2026.
What was Treace Medical Concepts, Inc.'s operating margin in 2025?
In 2025, Treace Medical Concepts, Inc.'s operating margin was -25.46%, compared with -26.60% in 2024.
How has Treace Medical Concepts, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Treace Medical Concepts, Inc.'s operating margin was highest in 2020 (1.49%) and lowest in 2023 (-27.48%).
How does Treace Medical Concepts, Inc.'s operating margin compare with similar companies?
Treace Medical Concepts, Inc.'s operating margin (-26.17%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.